CroDiab Registry

Croatian National Diabetes Registry was founded in 2000 with the aim of improving health care of persons with diabetes mellitus, assessing the prevalence and incidence of diabetes mellitus and its acute and chronic complications, monitoring morbidity, mortality and other clinical care quality indicators on a national level. Since 2004, registration has been mandatory for all general practitioners and hospital physicians treating persons with diabetes mellitus.

The overall number of patients registered in the CroDiab registry in 2015 was 260,092, while quality indicators were collected for 34,070 patients. Seventy-six percent of patients were treated with oral antidiabetic agents, 13% with oral antidiabetics and insulin, 11% with insulin alone, while less than 1% of patients were treated only with diet and physical activity. Glycemic regulation was good (HbA1c<6.5%) in 26.78% of cases, intermediate (6.5 %< HbA1c<7.5%) in 33.26% and poor (HbA1c>7.5%) in 39.96% of patients with average value (mean±standard deviation) of HbA1c being 7.46±1.51, fasting glucose 8.61±3.02, and postprandial glucose 9.37±3.35.

 

Scientific publications about the National Diabetes Programme and CroDiab Registry and its components & scientific publications that used registry as data tool published in journals indexed Current Contents, Medline/Embase/Excerpta medica, Scopus and other bibliographic databases

1. Jakubczyk M, Lipka I, Pawęska J, Niewada M, Rdzanek E, Zaletel J, Ramírez de Arellano A, Doležal T, Chekorova Mitreva B, Nagy B, Petrova G, Šarić T, Yfantopoulos J, Czech M. Cost of severe hypoglycaemia in nine European countries. J Med Econ. 2016 Oct;19(10):973-82. doi: 10.1080/13696998.2016.1188823.
2. Pavlov R, Topličan I, Vrcić Keglević M. Ten-Year Trends in the Morbidity of Diabetes Mellitus and Antidiabetic Drug Utilization in Croatia: A Study Based on Routinely Collected Data. Int J Family Med. 2016;2016:9837496. doi: 10.1155/2016/9837496
3. Pibernik-Okanović M., Hermanns N., Ajduković D., Kos J., Prašek M., Šekerija M., Vučić Lovrenčić M. Does treatment of subsyndromal depression improve depression-related and diabetes-related outcomes? A randomised controlled comparison of psychoeducation, physical exercise and enhanced treatment as usual. Trials. 2015; 16: 305.
4. Martina Tomić, Spomenka Ljubić, Snježana Kaštelan, Antonela Gverović Antunica, Anamarija Jazbec, and Tamara Poljičanin, “Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes,” Mediators of Inflammation, vol. 2013, Article ID 818671, 10 pages, 2013. doi:10.1155/2013/818671
5. Sarić T, Poljicanin T, Metelko Z. Cost of diabetes complications treatment: effect of improving glycemic control, blood pressure and lipid status on the occurrence of complications and costs of disease treatment]. Lijec Vjesn. 2013 May-Jun;135(5-6):162-71. Croatian.
6. Ajduković D., Pibernik-Okanović M., Šekerija M., Hermanns N. The Reach of Depression Screening Preceding Treatment: Are There Patterns of Patients’ Self-Selection? Int J Endocrinol. 2012; 2012: 148145.
7. Pibernik-Okanović M., Ajduković D., Vučić Lovrenčić M., Hermanns N. Does treatment of subsyndromal depression improve depression and diabetes related outcomes: protocol for a randomised controlled comparison of psycho-education, physical exercise and treatment as usual. Trials. 2011; 12: 17.
8. Šekerija M, Poljičanin T, Erjavec K, Liberati-Čizmek AM, Prašek M, Metelko Ž. Gender Differences in the Control of Cardiovascular Risk Factors in Patients with Type 2 Diabetes – A Cross-Sectional Study. Internal Medicine. 2011;51(2):161-166.
9. Poljičanin T, Pavlić-Renar I, Metelko Ž. Obesity in Type 2 Diabetes: Prevalence, Treatment Trends and Dilemmas. Coll Antropol. 2011;35(3):829-834.
10. Kern J, Erceg M, Poljičanin T. Efficacy of Public Health Surveillance Systems [Učinkovitost javnozdravstvenih informacijskih sustava] Acta Med Croat. 2010;64(5):415-23.
11. Poljičanin, Tamara; Šekerija, Mario; Metelko, Željko. CroDiab WEB and improvement of diabetes care at the primary health care level [CroDiab WEB i unapređenje dijabetološke skrbi u primarnoj zdravstvenoj zaštiti] Acta Med Croat. 2010;64(5):349-54.
12. Botica MV, Pavlić-Renar I, Poljicanin T, Balint I, Rapić M, Loncar J. CroDiab GP–follow up of diabetics protection in general medicine [CroDiab GP–praćenje zastite dijabetickih bolesnika u obiteljskoj medicini.] Acta Med Croat. 2007;61(1):19-24.
13. Poljičanin T, Pavlić-Renar I, Metelko Ž. Crodiab NET – Electronic diabetes registry [Crodiab NET – Registar osoba sa šećernom bolesti]. Acta Med Croat. 2005;59(3):185-9.

Conference abstracts published in journals indexed in Current Contents
1. Metelko Ž, Poljičanin T, Šekerija M, Ajduković, D. Impact of regular diabetes reporting on metabolic regulation in type 2 diabetes. 2010:59(Suppl. 1):A349.
2. Pavlić-Renar I, Poljičanin T, Metelko Ž. Slight weight gain: a price for better blood glucose control in type 2 diabetes? Diabetes. 2004;52(Suppl.2):A479.
3. Poljičanin T, Pavlić-Renar I, Metelko Ž. CroDiab NET and Diabetes Care Improvement. Diabetes. 2004;52(Suppl.2):A552.
4. Metelko Ž, Badanjak A, Božikov V, Đeldum Periša D, Drvodjelić- Šunjić E, Dumičić J, Kokić S, Magaš S, Poljičanin Filipović T, Slošić- Weiss S, Zjačić-Rotkvić V. CroDiab NET – A golden tool for diabetes service. Diabetes 2003;51(Suppl.2):A534.
5. Metelko Ž, Pavlić-Renar I, Poljičanin T. Questions from a medical record database. Diabetes 2003;51(Suppl.1):A523.
6. Pavlić-Renar I, Poljičanin-Filipović T, Metelko Ž. Cardiovascular risk profile at different levels of obesity in type 2 diabetes. Diabetes. 2003;51(Suppl. 2).
7. Poljičanin-Filipović T, Pavlić-Renar I, Metelko Ž. Type 1 and type 2 diabetes obesity prevalence – what is the difference? Diabetes. 2002;51(Suppl.2):A605.

Book chapters
1. Kern J, Erceg M, Poljičanin T, Sović S, Fišter K, Ivanković D, Vuletić S. Public Health ICT Based Surveillance System. In: Rodrigues, Joel J. P. C. ; de la Torre Díez, Isabel ; Sainz de Abajo, Beatriz, eds. Telemedicine and E-Health Services, Policies, and Applications: Advancements and Developments. Hershey, PA, USA : IGI Global, 2012. p. 369-396
2. Poljičanin T, Metelko Ž. Šećerna bolest. In: Vorko-Jović A, Strnad M, Rudan I, eds. Epidemiologija kroničnih nezaraznih. Zagreb: Medicinska naklada; 2010. p. 243-264.
3. Metelko Z, Pavlić-Renar I, Poljičanin-Filipović T, Car N, Dumičić J, Hercigonja R. CroDiabNET -sustav za praćenje dijabetološke skrbi. In: Kurjak A, Richter B, urednici. Telemedicina u Hrvatskoj: dostignuća i daljnji razvitak. Zagreb: Akademija medicinskih znanosti Hrvatske; 2001. p. 209-214.